Arp2/3-containing ventral F-actin waves are followed by integrin waves. by Lindsay B. Case (198881)

“…(C) LEFT: TIRFM image of a U2OS cell expressing F-tractin-tdTomato (red) and α_V integrin-EGFP (green). …”

The distribution of answers of each HIV-KQ-18 item from 6 regions in Indonesia. by Bustanul Arifin (7593353)

“…Item 1: Coughing and sneezing do not spread HIV; Item 2: A person can get HIV by sharing a glass of water with someone who has HIV; Item 3: Pulling out the penis before a man climaxes/cums keeps a woman from getting HIV during sex; Item 4: A woman can get HIV if she has anal sex with a man; Item 5: Showering, or washing one’s genitals/private parts, after sex keeps a person from getting HIV; Item 6: All pregnant woman infected with HIV quickly show serious signs of being infected; Item 7: People who have been infected with HIV quickly show serious signs of being infected; Item 8: There is a vaccine that can stop adults from getting HIV; Item 9: People are likely to get HIV by deep kissing, putting their tongue in their partner’s mouth, if their partner has HIV; Item 10: A woman cannot get HIV if she has sex during her period; Item 11: There is a female condom that can help decrease a woman’s chance of getting HIV; Item 12: A natural skin condom works better against HIV that does a latex condom; Item 13: A person will not get HIV if she or he is taking antibiotics; Item 14: Having sex with more than one partner can increase a person’s chance of being infected with HIV; Item 15: Taking a test for HIV one week after having sex will tell a person if she or he has HIV; Item 16: A person can get HIV by sitting in a hot tub or a swimming pool with a person who has HIV; Item 17: A person can get HIV from oral sex; Item 18: Using vaseline or baby oil with condoms lowers the chance of getting HIV.…”

Table1_Protein Posttranslational Signatures Identified in COVID-19 Patient Plasma.DOCX by Pavan Vedula (11984267)

“…Our results suggest a global change in protein processing and regulation that occurs in response to SARS-CoV-2, and the existence of a posttranslational COVID-19 signature that includes an elevation in threonine phosphorylation, a change in glycosylation, and a decrease in arginylation, an emerging posttranslational modification not previously implicated in infectious disease. …”

Table7_Protein Posttranslational Signatures Identified in COVID-19 Patient Plasma.DOCX by Pavan Vedula (11984267)

“…Our results suggest a global change in protein processing and regulation that occurs in response to SARS-CoV-2, and the existence of a posttranslational COVID-19 signature that includes an elevation in threonine phosphorylation, a change in glycosylation, and a decrease in arginylation, an emerging posttranslational modification not previously implicated in infectious disease. …”

Table4_Protein Posttranslational Signatures Identified in COVID-19 Patient Plasma.XLSX by Pavan Vedula (11984267)

“…Our results suggest a global change in protein processing and regulation that occurs in response to SARS-CoV-2, and the existence of a posttranslational COVID-19 signature that includes an elevation in threonine phosphorylation, a change in glycosylation, and a decrease in arginylation, an emerging posttranslational modification not previously implicated in infectious disease. …”

DataSheet1_Protein Posttranslational Signatures Identified in COVID-19 Patient Plasma.PDF by Pavan Vedula (11984267)

“…Our results suggest a global change in protein processing and regulation that occurs in response to SARS-CoV-2, and the existence of a posttranslational COVID-19 signature that includes an elevation in threonine phosphorylation, a change in glycosylation, and a decrease in arginylation, an emerging posttranslational modification not previously implicated in infectious disease. …”

Table2_Protein Posttranslational Signatures Identified in COVID-19 Patient Plasma.XLSX by Pavan Vedula (11984267)

“…Our results suggest a global change in protein processing and regulation that occurs in response to SARS-CoV-2, and the existence of a posttranslational COVID-19 signature that includes an elevation in threonine phosphorylation, a change in glycosylation, and a decrease in arginylation, an emerging posttranslational modification not previously implicated in infectious disease. …”

Table6_Protein Posttranslational Signatures Identified in COVID-19 Patient Plasma.XLSX by Pavan Vedula (11984267)

“…Our results suggest a global change in protein processing and regulation that occurs in response to SARS-CoV-2, and the existence of a posttranslational COVID-19 signature that includes an elevation in threonine phosphorylation, a change in glycosylation, and a decrease in arginylation, an emerging posttranslational modification not previously implicated in infectious disease. …”

Table8_Protein Posttranslational Signatures Identified in COVID-19 Patient Plasma.DOCX by Pavan Vedula (11984267)

“…Our results suggest a global change in protein processing and regulation that occurs in response to SARS-CoV-2, and the existence of a posttranslational COVID-19 signature that includes an elevation in threonine phosphorylation, a change in glycosylation, and a decrease in arginylation, an emerging posttranslational modification not previously implicated in infectious disease. …”

Presentation1_Protein Posttranslational Signatures Identified in COVID-19 Patient Plasma.pdf by Pavan Vedula (11984267)

“…Our results suggest a global change in protein processing and regulation that occurs in response to SARS-CoV-2, and the existence of a posttranslational COVID-19 signature that includes an elevation in threonine phosphorylation, a change in glycosylation, and a decrease in arginylation, an emerging posttranslational modification not previously implicated in infectious disease. …”

Table3_Protein Posttranslational Signatures Identified in COVID-19 Patient Plasma.XLSX by Pavan Vedula (11984267)

“…Our results suggest a global change in protein processing and regulation that occurs in response to SARS-CoV-2, and the existence of a posttranslational COVID-19 signature that includes an elevation in threonine phosphorylation, a change in glycosylation, and a decrease in arginylation, an emerging posttranslational modification not previously implicated in infectious disease. …”

Single-molecule properties of the Head1/Neck3 chimera. by Sarah Adio (374199)

“…Imperfect head-head coordination is most likely the reason for a higher detachment probability and the decrease in processivity.…”

OVOL1 and OVOL2 induce MET in mesenchymal prostate cancer cells. by Hernan Roca (466557)

“…</p> <p>(I) Schematic: The ZEB1 promoter with potential OVOL2 binding sites (orange triangles) according to the general consensus: 5’-A(A/T) (A/T) (C/A) (T/C)GTTA(T/A). Designed TaqMan primer-pairs are shown as black arrows. …”

Detection of apoptosis using flow cytometry. by Xi Fu (409609)

“…The arginine, homoarginine treatment significantly reduced the apoptosis of GA1 model cells, whereas the leucine and tyrosine treatment led to a slightly decrease in apoptosis that was not statistically significant. …”

Data_Sheet_1_The Association Between Shift Work and Immunological Biomarkers in Nurses.PDF by Bjørn Bjorvatn (35254)

Large-scale analysis by SAGE reveals new mechanisms of oncogene action-4 by Corinne Bresson (73910)

“…The fold repression is represented, corresponding to a decrease of mRNA accumulation in T2ECs expressing the transforming form of v-ErbA (VA) in comparison with T2ECs expressing the non-transforming form of v-ErbA (NTVA). …”

Gas exchange and millet phytomass under organic fertilization and graywater irrigation by José R. I. Silva (12819968)

Comparison of mAB 305-78-7 binding epitopes identified using DXMS and X-ray crystallography. by Alexey V. Gribenko (2183226)

REDUCTION IN KNEE PAIN SYMPTOMS IN ATHLETES USING AN ACUPUNCTURE PROTOCOL by Ana Paula Rehme Siqueira (6043091)

“…All participants reported experiencing a decrease in knee pain after treatment. The affected limbs showed an increase in average strength by 34% and 25% compared to the contralateral limb. …”

Characteristics of the latent classes. by Zhongheng Zhang (552412)

“…Each question was followed by an answer annotated by uppercase letters such as A, B, C, D and E. Annotations: how to assess the effectiveness of aerosol therapy (AssessEffect.How): A: Waveform B: Breathing sound C: Inspection of breathing appearance D: Not assess routinely E: others Filter exchange frequency (FilterExchange.frq) A: Every time after nebulization B: Once daily C: Twice a week D: Once a week E: More than once a week Nebulizer position for Metered dose nebulization (FixedDose.connector) A: Inspiratory limb near Y-piece B: Humidifier proximal to ventilator C: Humidifier proximal to patient D: others Use of holding chambers / spacers for metered dose nebulization (FixedDose.Container) A: yes B: no C: never use Use of aerosol therapy for invasive mechanical ventilation (IMV.nebulization.flg) A: Yes Type of jet nebulizer (JetNebulizer.type) A: external gas source B: external nebulizer pump C: nebulizer within ventilator D: others Nebulizer position for small-volume nebulizer (LowDose.connector) A: Inspiratory limb near Y-piece B: Humidifier proximal to ventilator C: Humidifier proximal to patient D: others Change of MV setting during nebulization (MVparameter.onNebu) A: Never change B: Increase PEEP C: Decrease inspiratory flow D: Use constant inspiratory flow E: Increase inspiratory time F: Use inspiratory pause G: Increase tidal volume H: Stop heated humidifier I: Place filter on expiratory circuit J: Sedation to avoid dyssynchrony K: Use base flow rate L: Others Type of nebulization drug (Nebu.Drug) A: bronchodilators B: antibiotics C: mucolytic agent D: topical steroids E: systemic steroids F: others Type of nebulizer (Nebulizer.type) A: ultrasonic nebulizer B: jet nebulizer C: vibrating mesh nebulizer D: metered dose E: others Use of protocol for aerosol therapy (NebuProtocal.flg) A: yes Use of nebulization during noninvasive mechanical ventilation (NIMV.nebulization.flg) A: yes PEEP level during aerosol therapy (PEEP.onNebu) A: 0 B: 1–5 C: 6–10 D: >10 E: PEEP not changed Model of ventilator setting during aerosol therapy (SpecialNebu) A: Pressure control B: Pressure support C: volume control D: SIMV E: High-frequency ventilation F: others.…”